In recent years, a significant improvement in left ventricular assist device (LVAD) technology
has occurred, and the continuous-flow devices currently used can last more than 10 years in …

Regardless of whether pulmonary hypertension (PH) results from increased pulmonary
venous pressure in left-sided heart diseases or from vascular remodeling and/or …

Right ventricular failure (RVF) is a significant cause of mortality in patients undergoing left
ventricular assist device (LVAD) implantation. Although right ventricular assist devices …

Objectives This study evaluated whether the postoperative pulmonary artery pulsatility index
(PAPi) is associated with postoperative right ventricular dysfunction after durable left …

Durable left ventricular assist devices (LVADs) have revolutionized the field of advanced
heart failure (HF) in the last 20 years. From 2013 to 2016 an estimated 6.2 million Americans …

Background The management of concomitant valvular lesions in patients undergoing left
ventricular assist device (LVAD) implantation remains a topic of debate. This systematic …

Left ventricular assist devices (LVADs) are increasingly used in patients with end-stage
heart failure (HF). There is a significant risk of HF admissions and hemocompatibility-related …

In this issue of the Journal, Defoe et al. 1 bring us one step closer to understanding a
technically challenging question—what is the best way to assess the right ventricle (RV) in a …

Objective To comprehensively assess relevant institutional variations in anesthesia and
intensive care management during left ventricular assist device (LVAD) implantation. Design …

The past 10 years have seen an increase in left ventricular assist device (LVAD)
implantation, sicker patients at implant, and improved long-term LVAD survival. 1 This article …